发布: 2019年07月20日第9卷第14期 DOI: 10.21769/BioProtoc.3311 浏览次数: 8228
评审: Alexandros AlexandratosXinyan ZhangCristina Isabel Carvalho
Abstract
The in vitro and in vivo genotoxicity of new metallodrugs either as Small Bioactive Molecules (SBAMs) or Conjugates of Metals with Drugs (CoMeDs) is evaluated by the micronucleus test and the Allium cepa assay, respectively. Fetal lung fibroblast cells (MRC-5), normal human corneal epithelial cells (HCEC) and immortalized human keratinocytes cells (HaCaT) were incubated with solutions of SBAMs or CoMeDs at their IC50 values for 48 h (the concentration of a compound which is required to inhibit the cells growth by 50% in relation to the non-treated cells). The micronucleus abundance percentage towards the corresponding one, of the non-treated cells indicates the in vitro genotoxicity of the formulations. The in vivo Allium cepa test comprises the exposing of the plant Allium cepa roots to an SBAMs or a CoMeDs solution for 48 h. The percentages of the mitotic index, the chromosome aberrations, the nuclear abnormalities and the presence of the micronucleus are calculated indicating the in vivo genotoxicity of the agent.
Keywords: Biological inorganic chemistry (生物无机化学)Background
Inorganic biochemistry, biological inorganic chemistry or bioinorganic chemistry is a multidiscipline scientific field which combines biological inorganic chemistry, biochemistry, biology, medicinal chemistry, microbiology and other fields (Latsis et al., 2018). Nowadays, the research on the design and development of new metallodrugs [Small Bioactive Molecules (SBAMs) or Conjugates of Metals with Drugs (CoMeDs)] against numerous cancer types, includes their biological activity towards cancerous and non cancerous models (Banti et al., 2016; Sainis et al., 2016; Banti et al., 2018; Chrysouli et al., 2018a and 2018b; Latsis et al., 2018; Milionis et al., 2018; Stathopoulou et al., 2018; Banti et al., 2019; Polychronis et al., 2019). Especially, the development of new SBAMs or CoMeDs imposes the need to assess their potential in vitro and in vivo toxicity against experimental models in order to check their potential risks (Banti et al., 2016; Sainis et al., 2016; Banti et al., 2018; Chrysouli et al., 2018a and 2018b; Latsis et al., 2018; Milionis et al., 2018; Stathopoulou et al., 2018; Banti et al., 2019; Polychronis et al., 2019). Therefore, the micronucleus assay has been developed in monitoring genetic damage in normal human cells as it is a sensitive tool for toxicity screening and it is capable in reducing the use of animals in toxicological testing (Sahu et al., 2014). The presence of micronucleus (MN) is a biomarker of mutagenic, genotoxic, or teratogenic agent influence (Torres-Bugarín et al., 2014). The in vitro genotoxicity is calculated by checking the micronucleus frequency, upon treatment of normal cells by an agent at the concentration of its IC50 value (Chrysouli et al., 2018a and 2018b; Latsis et al., 2018; Milionis et al., 2018; Sainis et al., 2016; Stathopoulou et al., 2018). The
Materials and Reagents
Equipment
Software
Procedure
文章信息
版权信息
© 2019 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Banti, C. N. and Hadjikakou, S. K. (2019). Evaluation of Genotoxicity by Micronucleus Assay in vitro and by Allium cepa Test in vivo. Bio-protocol 9(14): e3311. DOI: 10.21769/BioProtoc.3311.
分类
癌症生物学 > 癌症生物化学 > 基因毒性
生物化学 > DNA > 单分子活性
细胞生物学 > 细胞染色 > 核酸
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link